 |
FDA Raptiva Reports and NewsOur law firm is investigating cases involving the drug Raptiva. Patients taking Raptiva need to be aware that the psoriasis drug has been recalled. This page will be updated as more information becomes available from the FDA or the Center for Drug Evaluation and Research. |
B R E A K I N G N E W S
Psoriasis Drug Raptiva Recalled
April 8, 2009
Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary recall of Raptiva from the U.S. market. The FDA has issued a statement concerning the Raptiva recall -- FDA Raptiva Recall Statement.
FDA Reports and Raptiva News
- 04/08/2009 - FDA Raptiva Recall Statement
- 04/08/2009 - Raptiva Dear Patient Letter
- 04/08/2009 - Raptiva Dear Healthcare Professional Letter
- 03/13/2009 - Medication Guide for Raptiva (PDF)
- 03/13/2009 - FDA approved Medication Guide for Raptiva
- 02/19/2009 - FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva
- 10/16/2008 - FDA Approves Updated Labeling for Psoriasis Drug Raptiva
Speak to a Lawyer
If you or someone you love is experiencing severe side effects from the use of Raptiva, please contact your doctor immediately for a full evaluation. If you would like to have more information regarding your legal rights, please fill out our free legal evaluation form on the right. Only a little information is required, but the more information you share with our law firm the more detailed our answers will be in addressing your specific concerns. Please keep in mind that certain states have a statute of limitations that limits the amount of time you have to file a lawsuit or seek legal action. Contact our law firm immediately so we may explain the rights and options available to you and your family.
